

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 8.44023997 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 7.88003497 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.37400383 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.37400383 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.05453756 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.05453756 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.64040108 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.62214578 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.00293274 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 6.00293274 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 6.00293274 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.89925751 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.80474802 |
| 14 | urea cycle (GO:0000050) | 5.69871935 |
| 15 | urea metabolic process (GO:0019627) | 5.69871935 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.68124847 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.64960503 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.64108388 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.57297206 |
| 20 | oxidative demethylation (GO:0070989) | 5.49381009 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.36391608 |
| 22 | cysteine metabolic process (GO:0006534) | 5.29645428 |
| 23 | nitrogen cycle metabolic process (GO:0071941) | 5.23114143 |
| 24 | protein carboxylation (GO:0018214) | 5.18885588 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.18885588 |
| 26 | regulation of fibrinolysis (GO:0051917) | 5.18792609 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 5.18147891 |
| 28 | regulation of cholesterol esterification (GO:0010872) | 5.17770743 |
| 29 | regulation of plasminogen activation (GO:0010755) | 5.16018326 |
| 30 | complement activation, alternative pathway (GO:0006957) | 5.08472307 |
| 31 | regulation of protein activation cascade (GO:2000257) | 5.07078812 |
| 32 | bile acid metabolic process (GO:0008206) | 5.06097415 |
| 33 | regulation of triglyceride catabolic process (GO:0010896) | 5.05150119 |
| 34 | reverse cholesterol transport (GO:0043691) | 5.00118765 |
| 35 | serine family amino acid catabolic process (GO:0009071) | 4.96477869 |
| 36 | ethanol metabolic process (GO:0006067) | 4.93661785 |
| 37 | plasma lipoprotein particle remodeling (GO:0034369) | 4.88792442 |
| 38 | protein-lipid complex remodeling (GO:0034368) | 4.88792442 |
| 39 | macromolecular complex remodeling (GO:0034367) | 4.88792442 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.88106573 |
| 41 | phospholipid efflux (GO:0033700) | 4.87026149 |
| 42 | aromatic amino acid family metabolic process (GO:0009072) | 4.82163888 |
| 43 | homocysteine metabolic process (GO:0050667) | 4.75738845 |
| 44 | negative regulation of blood coagulation (GO:0030195) | 4.75560626 |
| 45 | negative regulation of hemostasis (GO:1900047) | 4.75560626 |
| 46 | regulation of complement activation (GO:0030449) | 4.73741622 |
| 47 | phenylpropanoid metabolic process (GO:0009698) | 4.69452208 |
| 48 | triglyceride homeostasis (GO:0070328) | 4.67805611 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.67805611 |
| 50 | tyrosine metabolic process (GO:0006570) | 4.65597092 |
| 51 | protein activation cascade (GO:0072376) | 4.63344904 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 4.56917665 |
| 53 | bile acid and bile salt transport (GO:0015721) | 4.55161904 |
| 54 | lysine catabolic process (GO:0006554) | 4.53341035 |
| 55 | lysine metabolic process (GO:0006553) | 4.53341035 |
| 56 | alpha-amino acid catabolic process (GO:1901606) | 4.51804442 |
| 57 | plasma lipoprotein particle clearance (GO:0034381) | 4.39107030 |
| 58 | * negative regulation of sterol transport (GO:0032372) | 4.38610156 |
| 59 | * negative regulation of cholesterol transport (GO:0032375) | 4.38610156 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 4.38587240 |
| 61 | S-adenosylmethionine metabolic process (GO:0046500) | 4.37339900 |
| 62 | acute-phase response (GO:0006953) | 4.37147399 |
| 63 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.36771287 |
| 64 | drug catabolic process (GO:0042737) | 4.35332372 |
| 65 | alkaloid metabolic process (GO:0009820) | 4.34907837 |
| 66 | cellular glucuronidation (GO:0052695) | 4.33695886 |
| 67 | negative regulation of coagulation (GO:0050819) | 4.32908979 |
| 68 | plasma lipoprotein particle assembly (GO:0034377) | 4.29079529 |
| 69 | coenzyme catabolic process (GO:0009109) | 4.28067777 |
| 70 | * cholesterol efflux (GO:0033344) | 4.27317948 |
| 71 | regulation of humoral immune response (GO:0002920) | 4.25505682 |
| 72 | indolalkylamine metabolic process (GO:0006586) | 4.25145845 |
| 73 | glycine metabolic process (GO:0006544) | 4.24456438 |
| 74 | negative regulation of wound healing (GO:0061045) | 4.24317777 |
| 75 | imidazole-containing compound metabolic process (GO:0052803) | 4.22448477 |
| 76 | glutamate metabolic process (GO:0006536) | 4.19265107 |
| 77 | cellular amino acid catabolic process (GO:0009063) | 4.15794551 |
| 78 | cellular biogenic amine catabolic process (GO:0042402) | 4.14997559 |
| 79 | amine catabolic process (GO:0009310) | 4.14997559 |
| 80 | regulation of bile acid biosynthetic process (GO:0070857) | 4.09251363 |
| 81 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.07507079 |
| 82 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.07507079 |
| 83 | benzene-containing compound metabolic process (GO:0042537) | 4.06051338 |
| 84 | serine family amino acid metabolic process (GO:0009069) | 4.05658388 |
| 85 | negative regulation of protein activation cascade (GO:2000258) | 4.04136844 |
| 86 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.02621504 |
| 87 | positive regulation of hemostasis (GO:1900048) | 4.02092976 |
| 88 | positive regulation of blood coagulation (GO:0030194) | 4.02092976 |
| 89 | hormone catabolic process (GO:0042447) | 4.00635743 |
| 90 | ethanol oxidation (GO:0006069) | 4.00490335 |
| 91 | low-density lipoprotein particle remodeling (GO:0034374) | 4.00001453 |
| 92 | arginine metabolic process (GO:0006525) | 3.98684710 |
| 93 | cellular modified amino acid catabolic process (GO:0042219) | 3.98458859 |
| 94 | serine family amino acid biosynthetic process (GO:0009070) | 3.93488800 |
| 95 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.90440331 |
| 96 | positive regulation of lipid catabolic process (GO:0050996) | 3.88153766 |
| 97 | protein-lipid complex assembly (GO:0065005) | 3.86559482 |
| 98 | * cholesterol homeostasis (GO:0042632) | 3.86037074 |
| 99 | uronic acid metabolic process (GO:0006063) | 3.84708678 |
| 100 | glucuronate metabolic process (GO:0019585) | 3.84708678 |
| 101 | flavonoid metabolic process (GO:0009812) | 3.84333972 |
| 102 | fibrinolysis (GO:0042730) | 3.83636508 |
| 103 | aldehyde catabolic process (GO:0046185) | 3.82737594 |
| 104 | phospholipid homeostasis (GO:0055091) | 3.81077852 |
| 105 | regulation of cholesterol homeostasis (GO:2000188) | 3.80073303 |
| 106 | * sterol homeostasis (GO:0055092) | 3.79603718 |
| 107 | ketone body metabolic process (GO:1902224) | 3.79379415 |
| 108 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.77794331 |
| 109 | plasma lipoprotein particle organization (GO:0071827) | 3.77077900 |
| 110 | response to mercury ion (GO:0046689) | 3.72551000 |
| 111 | positive regulation of coagulation (GO:0050820) | 3.72449432 |
| 112 | negative regulation of lipase activity (GO:0060192) | 3.71817911 |
| 113 | lipoprotein metabolic process (GO:0042157) | 3.69404434 |
| 114 | cofactor catabolic process (GO:0051187) | 3.68676409 |
| 115 | cytolysis (GO:0019835) | 3.67692514 |
| 116 | carboxylic acid catabolic process (GO:0046395) | 3.67249625 |
| 117 | organic acid catabolic process (GO:0016054) | 3.67249625 |
| 118 | blood coagulation, intrinsic pathway (GO:0007597) | 3.66772539 |
| 119 | heme transport (GO:0015886) | 3.66743681 |
| 120 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.66541974 |
| 121 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.66541974 |
| 122 | exogenous drug catabolic process (GO:0042738) | 3.62380140 |
| 123 | short-chain fatty acid metabolic process (GO:0046459) | 3.62023453 |
| 124 | complement activation, classical pathway (GO:0006958) | 3.60727054 |
| 125 | acetyl-CoA metabolic process (GO:0006084) | 3.59516552 |
| 126 | drug metabolic process (GO:0017144) | 3.57389536 |
| 127 | complement activation (GO:0006956) | 3.57058164 |
| 128 | opsonization (GO:0008228) | 3.52593136 |
| 129 | xenobiotic metabolic process (GO:0006805) | 3.50185513 |
| 130 | regulation of apoptotic cell clearance (GO:2000425) | 3.45086493 |
| 131 | drug transmembrane transport (GO:0006855) | 3.43513801 |
| 132 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.42810880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.31177623 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.18155369 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.92880037 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.49024377 |
| 5 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.11000177 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.95993163 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.77235072 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.03069746 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.85080868 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.14181883 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.07784263 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.05170676 |
| 13 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7017660 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89651861 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.65116996 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54054414 |
| 17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.53759921 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.52416257 |
| 19 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.47360544 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29578799 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27277814 |
| 22 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.17751910 |
| 23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.16521962 |
| 24 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15842530 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.14614990 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11013177 |
| 27 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.09002550 |
| 28 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06943527 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05204631 |
| 30 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.02127054 |
| 31 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.97589351 |
| 32 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95456070 |
| 33 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.86266875 |
| 34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.85957456 |
| 35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84808905 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.84808882 |
| 37 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82906087 |
| 38 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81319327 |
| 39 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80413301 |
| 40 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80300827 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.78594319 |
| 42 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.76478614 |
| 43 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75963790 |
| 44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.75270838 |
| 45 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74917928 |
| 46 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.74076894 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.73418156 |
| 48 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73210326 |
| 49 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.73015550 |
| 50 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.72564548 |
| 51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.71906479 |
| 52 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71618444 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.69740373 |
| 54 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69624490 |
| 55 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.68419806 |
| 56 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68418769 |
| 57 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.66797409 |
| 58 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.65883184 |
| 59 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.65514602 |
| 60 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.64885227 |
| 61 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.64042193 |
| 62 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.63041423 |
| 63 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62502747 |
| 64 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62457607 |
| 65 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.62281159 |
| 66 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.62281159 |
| 67 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.62120676 |
| 68 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.61816872 |
| 69 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.61562069 |
| 70 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61083928 |
| 71 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.60615284 |
| 72 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.60186102 |
| 73 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.59140684 |
| 74 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.57378240 |
| 75 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.56708518 |
| 76 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.56683907 |
| 77 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.56534048 |
| 78 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.56511686 |
| 79 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56348185 |
| 80 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.56163262 |
| 81 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.56028703 |
| 82 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.55701617 |
| 83 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.54314050 |
| 84 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.54017014 |
| 85 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.53966548 |
| 86 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53934322 |
| 87 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.53900306 |
| 88 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52988339 |
| 89 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52271463 |
| 90 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.51657012 |
| 91 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.51185962 |
| 92 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.50707441 |
| 93 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.50703848 |
| 94 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50678988 |
| 95 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.50340503 |
| 96 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.50109452 |
| 97 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.49958031 |
| 98 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.49899242 |
| 99 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.49579549 |
| 100 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.49579150 |
| 101 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49546423 |
| 102 | GATA2_19941826_ChIP-Seq_K562_Human | 0.48574248 |
| 103 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.48557181 |
| 104 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.48006504 |
| 105 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.47829304 |
| 106 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47738312 |
| 107 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47455995 |
| 108 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.46565918 |
| 109 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45661669 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.45126106 |
| 111 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44525503 |
| 112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.44475396 |
| 113 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.44241853 |
| 114 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.43653889 |
| 115 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42849819 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.42726300 |
| 117 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40687888 |
| 118 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.38532111 |
| 119 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.38014024 |
| 120 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37741695 |
| 121 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.37741069 |
| 122 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.37584553 |
| 123 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.37543865 |
| 124 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.37373401 |
| 125 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.36128168 |
| 126 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.36078999 |
| 127 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.36064398 |
| 128 | NCOR_22424771_ChIP-Seq_293T_Human | 0.35862160 |
| 129 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.35642349 |
| 130 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.34822904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.20018015 |
| 2 | * MP0002139_abnormal_hepatobiliary_system | 7.56932375 |
| 3 | * MP0005085_abnormal_gallbladder_physiolo | 6.30532359 |
| 4 | MP0005365_abnormal_bile_salt | 6.14658942 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.30847196 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.15236671 |
| 7 | MP0003252_abnormal_bile_duct | 4.14866354 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.69038900 |
| 9 | MP0009840_abnormal_foam_cell | 3.53922448 |
| 10 | MP0005083_abnormal_biliary_tract | 2.93868368 |
| 11 | * MP0001666_abnormal_nutrient_absorption | 2.91622173 |
| 12 | MP0005332_abnormal_amino_acid | 2.73609316 |
| 13 | MP0003195_calcinosis | 2.67206204 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.27827228 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.20274110 |
| 16 | MP0000609_abnormal_liver_physiology | 2.16743137 |
| 17 | * MP0002118_abnormal_lipid_homeostasis | 2.09600282 |
| 18 | MP0003868_abnormal_feces_composition | 1.88294240 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.84277626 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.80846383 |
| 21 | MP0009697_abnormal_copulation | 1.72720457 |
| 22 | MP0001764_abnormal_homeostasis | 1.65789000 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53791523 |
| 24 | MP0005451_abnormal_body_composition | 1.48775832 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.26653219 |
| 26 | MP0003011_delayed_dark_adaptation | 1.25457969 |
| 27 | MP0009643_abnormal_urine_homeostasis | 1.25327605 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.22201964 |
| 29 | MP0000598_abnormal_liver_morphology | 1.15340262 |
| 30 | MP0003186_abnormal_redox_activity | 1.13243214 |
| 31 | MP0002254_reproductive_system_inflammat | 1.11583694 |
| 32 | MP0005647_abnormal_sex_gland | 1.05787534 |
| 33 | MP0000604_amyloidosis | 1.05601892 |
| 34 | MP0009764_decreased_sensitivity_to | 1.03570578 |
| 35 | MP0002132_abnormal_respiratory_system | 0.99853215 |
| 36 | MP0009763_increased_sensitivity_to | 0.97316602 |
| 37 | MP0003879_abnormal_hair_cell | 0.95230029 |
| 38 | MP0005084_abnormal_gallbladder_morpholo | 0.92002005 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 0.90252239 |
| 40 | * MP0009642_abnormal_blood_homeostasis | 0.86877749 |
| 41 | MP0008469_abnormal_protein_level | 0.86260699 |
| 42 | MP0010368_abnormal_lymphatic_system | 0.84494812 |
| 43 | MP0005408_hypopigmentation | 0.82856850 |
| 44 | MP0002876_abnormal_thyroid_physiology | 0.82363895 |
| 45 | MP0005376_homeostasis/metabolism_phenot | 0.81198764 |
| 46 | MP0009765_abnormal_xenobiotic_induced | 0.80133960 |
| 47 | MP0002078_abnormal_glucose_homeostasis | 0.77297146 |
| 48 | MP0006036_abnormal_mitochondrial_physio | 0.76676539 |
| 49 | MP0001915_intracranial_hemorrhage | 0.74370233 |
| 50 | MP0005670_abnormal_white_adipose | 0.72733771 |
| 51 | MP0002971_abnormal_brown_adipose | 0.72474989 |
| 52 | MP0005266_abnormal_metabolism | 0.70966922 |
| 53 | MP0009053_abnormal_anal_canal | 0.69737389 |
| 54 | MP0005334_abnormal_fat_pad | 0.69248241 |
| 55 | MP0005448_abnormal_energy_balance | 0.67312916 |
| 56 | MP0002822_catalepsy | 0.67206705 |
| 57 | MP0003183_abnormal_peptide_metabolism | 0.66465001 |
| 58 | MP0005220_abnormal_exocrine_pancreas | 0.64954810 |
| 59 | MP0005535_abnormal_body_temperature | 0.63696326 |
| 60 | MP0004130_abnormal_muscle_cell | 0.62756611 |
| 61 | MP0003690_abnormal_glial_cell | 0.61847161 |
| 62 | MP0003329_amyloid_beta_deposits | 0.60256813 |
| 63 | MP0000566_synostosis | 0.59927940 |
| 64 | MP0001756_abnormal_urination | 0.57448914 |
| 65 | MP0001661_extended_life_span | 0.57351781 |
| 66 | MP0000639_abnormal_adrenal_gland | 0.55547033 |
| 67 | MP0002249_abnormal_larynx_morphology | 0.55149841 |
| 68 | MP0006035_abnormal_mitochondrial_morpho | 0.54558086 |
| 69 | MP0005058_abnormal_lysosome_morphology | 0.54366416 |
| 70 | MP0002282_abnormal_trachea_morphology | 0.53828112 |
| 71 | MP0005464_abnormal_platelet_physiology | 0.52987339 |
| 72 | MP0002089_abnormal_postnatal_growth/wei | 0.52175695 |
| 73 | MP0003718_maternal_effect | 0.52087485 |
| 74 | MP0002168_other_aberrant_phenotype | 0.51425759 |
| 75 | MP0003638_abnormal_response/metabolism_ | 0.49645076 |
| 76 | MP0005023_abnormal_wound_healing | 0.48943145 |
| 77 | MP0002136_abnormal_kidney_physiology | 0.47757363 |
| 78 | MP0005395_other_phenotype | 0.46749926 |
| 79 | MP0008872_abnormal_physiological_respon | 0.45576023 |
| 80 | MP0008873_increased_physiological_sensi | 0.45232666 |
| 81 | MP0004264_abnormal_extraembryonic_tissu | 0.45107183 |
| 82 | MP0008874_decreased_physiological_sensi | 0.44536017 |
| 83 | MP0010234_abnormal_vibrissa_follicle | 0.42766739 |
| 84 | MP0004782_abnormal_surfactant_physiolog | 0.42312889 |
| 85 | MP0003953_abnormal_hormone_level | 0.41486434 |
| 86 | MP0005187_abnormal_penis_morphology | 0.41390929 |
| 87 | MP0005166_decreased_susceptibility_to | 0.40203106 |
| 88 | MP0002796_impaired_skin_barrier | 0.40132061 |
| 89 | MP0005409_darkened_coat_color | 0.39673731 |
| 90 | MP0005248_abnormal_Harderian_gland | 0.39621069 |
| 91 | MP0003436_decreased_susceptibility_to | 0.39603783 |
| 92 | MP0009785_altered_susceptibility_to | 0.39093409 |
| 93 | MP0002928_abnormal_bile_duct | 0.38082549 |
| 94 | MP0005666_abnormal_adipose_tissue | 0.37778654 |
| 95 | MP0003075_altered_response_to | 0.36576328 |
| 96 | MP0009115_abnormal_fat_cell | 0.36171343 |
| 97 | MP0003724_increased_susceptibility_to | 0.35970268 |
| 98 | MP0000579_abnormal_nail_morphology | 0.35814721 |
| 99 | MP0009384_cardiac_valve_regurgitation | 0.35114312 |
| 100 | MP0005164_abnormal_response_to | 0.34051854 |
| 101 | MP0000230_abnormal_systemic_arterial | 0.33544699 |
| 102 | MP0000249_abnormal_blood_vessel | 0.32482715 |
| 103 | MP0009672_abnormal_birth_weight | 0.31516731 |
| 104 | MP0001243_abnormal_dermal_layer | 0.30379599 |
| 105 | MP0006082_CNS_inflammation | 0.30350346 |
| 106 | MP0002837_dystrophic_cardiac_calcinosis | 0.30310736 |
| 107 | MP0001881_abnormal_mammary_gland | 0.29746664 |
| 108 | MP0004381_abnormal_hair_follicle | 0.29305243 |
| 109 | MP0004883_abnormal_blood_vessel | 0.28998551 |
| 110 | MP0010155_abnormal_intestine_physiology | 0.28215144 |
| 111 | MP0004043_abnormal_pH_regulation | 0.28042666 |
| 112 | MP0001845_abnormal_inflammatory_respons | 0.27878492 |
| 113 | MP0002970_abnormal_white_adipose | 0.27666529 |
| 114 | MP0001853_heart_inflammation | 0.27345105 |
| 115 | MP0000538_abnormal_urinary_bladder | 0.26570106 |
| 116 | MP0005167_abnormal_blood-brain_barrier | 0.25655039 |
| 117 | MP0000467_abnormal_esophagus_morphology | 0.24691123 |
| 118 | MP0003632_abnormal_nervous_system | 0.19688408 |
| 119 | MP0001851_eye_inflammation | 0.18730051 |
| 120 | MP0003959_abnormal_lean_body | 0.18270925 |
| 121 | MP0004142_abnormal_muscle_tone | 0.17382367 |
| 122 | MP0002135_abnormal_kidney_morphology | 0.17375858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.32839143 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.27678521 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.24108355 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.87446028 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.71643428 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.41934258 |
| 7 | Xanthomatosis (HP:0000991) | 6.33397838 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.43939442 |
| 9 | Complement deficiency (HP:0004431) | 5.12010481 |
| 10 | Hypolipoproteinemia (HP:0010981) | 5.01877145 |
| 11 | Epidermoid cyst (HP:0200040) | 4.61471283 |
| 12 | Hyperammonemia (HP:0001987) | 4.61210402 |
| 13 | Joint hemorrhage (HP:0005261) | 4.59015272 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.56523429 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.54261650 |
| 16 | Fat malabsorption (HP:0002630) | 4.35110282 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.31663295 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.30823119 |
| 19 | Hyperglycinemia (HP:0002154) | 4.30259091 |
| 20 | Ketosis (HP:0001946) | 4.21526123 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.21069738 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 4.18941396 |
| 23 | Conjugated hyperbilirubinemia (HP:0002908) | 4.14331764 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 4.13777416 |
| 25 | Hyperglycinuria (HP:0003108) | 4.08663714 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.00227408 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 4.00227408 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.82152063 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.81574949 |
| 30 | Abnormality of complement system (HP:0005339) | 3.73190354 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.67479724 |
| 32 | Hyperbilirubinemia (HP:0002904) | 3.41888945 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.40353832 |
| 34 | * Hypercholesterolemia (HP:0003124) | 3.35598104 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.32091930 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.12981714 |
| 37 | Steatorrhea (HP:0002570) | 3.09574088 |
| 38 | Acanthocytosis (HP:0001927) | 3.07605178 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.05813555 |
| 40 | Ketoacidosis (HP:0001993) | 3.00693410 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 2.94585972 |
| 42 | Osteomalacia (HP:0002749) | 2.94288685 |
| 43 | Myocardial infarction (HP:0001658) | 2.93117583 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 2.90554724 |
| 45 | Metabolic acidosis (HP:0001942) | 2.85752313 |
| 46 | Hypochromic microcytic anemia (HP:0004840) | 2.85654943 |
| 47 | Spontaneous abortion (HP:0005268) | 2.85159528 |
| 48 | Skin nodule (HP:0200036) | 2.82449283 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.78396539 |
| 50 | Systemic lupus erythematosus (HP:0002725) | 2.68555183 |
| 51 | Malnutrition (HP:0004395) | 2.66594331 |
| 52 | Vascular calcification (HP:0004934) | 2.61473103 |
| 53 | Lethargy (HP:0001254) | 2.56765522 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.55178273 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.55178273 |
| 56 | Purpura (HP:0000979) | 2.53019400 |
| 57 | Abnormal gallbladder physiology (HP:0012438) | 2.45291516 |
| 58 | Cholecystitis (HP:0001082) | 2.45291516 |
| 59 | Hypoglycemic seizures (HP:0002173) | 2.44334088 |
| 60 | Hyperphosphaturia (HP:0003109) | 2.43577702 |
| 61 | Spastic diplegia (HP:0001264) | 2.41810387 |
| 62 | Glomerulonephritis (HP:0000099) | 2.38383584 |
| 63 | Irritability (HP:0000737) | 2.34894021 |
| 64 | Gout (HP:0001997) | 2.33368462 |
| 65 | Mitral stenosis (HP:0001718) | 2.32374252 |
| 66 | Cardiovascular calcification (HP:0011915) | 2.31475268 |
| 67 | Cerebral edema (HP:0002181) | 2.30622009 |
| 68 | Amyloidosis (HP:0011034) | 2.27715171 |
| 69 | Abnormality of proline metabolism (HP:0010907) | 2.24946951 |
| 70 | Hydroxyprolinuria (HP:0003080) | 2.24946951 |
| 71 | Neonatal onset (HP:0003623) | 2.23169831 |
| 72 | Esophageal varix (HP:0002040) | 2.20025635 |
| 73 | Sensorimotor neuropathy (HP:0007141) | 2.19123837 |
| 74 | Pancreatitis (HP:0001733) | 2.18528833 |
| 75 | Late onset (HP:0003584) | 2.17971277 |
| 76 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.16606562 |
| 77 | Abnormal urine phosphate concentration (HP:0012599) | 2.15221693 |
| 78 | Pulmonary embolism (HP:0002204) | 2.13693101 |
| 79 | Fair hair (HP:0002286) | 2.12079399 |
| 80 | Brushfield spots (HP:0001088) | 2.09802328 |
| 81 | Menorrhagia (HP:0000132) | 2.09240304 |
| 82 | Gingival bleeding (HP:0000225) | 2.08341821 |
| 83 | * Abnormal gallbladder morphology (HP:0012437) | 2.06252429 |
| 84 | Vomiting (HP:0002013) | 2.05759311 |
| 85 | Generalized aminoaciduria (HP:0002909) | 2.02580137 |
| 86 | Enlarged kidneys (HP:0000105) | 2.02141753 |
| 87 | Hemorrhage of the eye (HP:0011885) | 2.02011983 |
| 88 | Opisthotonus (HP:0002179) | 2.00643341 |
| 89 | Elevated alkaline phosphatase (HP:0003155) | 1.99760125 |
| 90 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.98859205 |
| 91 | Arthropathy (HP:0003040) | 1.98698292 |
| 92 | Rickets (HP:0002748) | 1.97095634 |
| 93 | Thrombophlebitis (HP:0004418) | 1.96819734 |
| 94 | * Cholelithiasis (HP:0001081) | 1.95374522 |
| 95 | Abnormality of the Achilles tendon (HP:0005109) | 1.94253573 |
| 96 | Bifid scrotum (HP:0000048) | 1.92832505 |
| 97 | Abnormality of vitamin metabolism (HP:0100508) | 1.90567848 |
| 98 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89793418 |
| 99 | Abnormal cartilage morphology (HP:0002763) | 1.89549007 |
| 100 | Joint swelling (HP:0001386) | 1.89439914 |
| 101 | Neonatal hypoglycemia (HP:0001998) | 1.88858569 |
| 102 | * Poikilocytosis (HP:0004447) | 1.88139143 |
| 103 | Reduced antithrombin III activity (HP:0001976) | 1.87656773 |
| 104 | Abnormality of iron homeostasis (HP:0011031) | 1.87302951 |
| 105 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.86778587 |
| 106 | Renal cortical cysts (HP:0000803) | 1.84342974 |
| 107 | Glycosuria (HP:0003076) | 1.83633446 |
| 108 | Abnormality of urine glucose concentration (HP:0011016) | 1.83633446 |
| 109 | Hypophosphatemic rickets (HP:0004912) | 1.83394021 |
| 110 | Elevated hepatic transaminases (HP:0002910) | 1.81413950 |
| 111 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80188133 |
| 112 | Hyperglycemia (HP:0003074) | 1.77417312 |
| 113 | Hypophosphatemia (HP:0002148) | 1.77101685 |
| 114 | Nephritis (HP:0000123) | 1.76942192 |
| 115 | Alkalosis (HP:0001948) | 1.76295388 |
| 116 | Increased serum ferritin (HP:0003281) | 1.76196599 |
| 117 | Proximal tubulopathy (HP:0000114) | 1.75430366 |
| 118 | Abnormal tarsal ossification (HP:0008369) | 1.72332555 |
| 119 | Gangrene (HP:0100758) | 1.67685506 |
| 120 | Cerebral palsy (HP:0100021) | 1.64615682 |
| 121 | Epistaxis (HP:0000421) | 1.63207800 |
| 122 | Nephrolithiasis (HP:0000787) | 1.57544507 |
| 123 | Potter facies (HP:0002009) | 1.54896138 |
| 124 | Facial shape deformation (HP:0011334) | 1.54896138 |
| 125 | Widely patent fontanelles and sutures (HP:0004492) | 1.51684712 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.76080237 |
| 2 | SIK1 | 4.45357402 |
| 3 | FGFR4 | 4.40314970 |
| 4 | ERN1 | 4.34122934 |
| 5 | TAOK3 | 3.16384574 |
| 6 | ACVR1B | 2.94649300 |
| 7 | INSRR | 2.94073248 |
| 8 | ERBB4 | 2.72616542 |
| 9 | MST1R | 2.68070958 |
| 10 | FRK | 2.47666139 |
| 11 | MAP2K4 | 2.25646561 |
| 12 | PKN2 | 2.24109139 |
| 13 | PRPF4B | 2.02569612 |
| 14 | NTRK3 | 1.91207775 |
| 15 | MAPK11 | 1.85715094 |
| 16 | FLT3 | 1.82508215 |
| 17 | PTK6 | 1.74153650 |
| 18 | LATS1 | 1.72433595 |
| 19 | PIK3CG | 1.72212963 |
| 20 | TYK2 | 1.69300287 |
| 21 | TRIB3 | 1.63134721 |
| 22 | GRK6 | 1.56517902 |
| 23 | MAP3K10 | 1.40969127 |
| 24 | DAPK2 | 1.36561564 |
| 25 | ABL2 | 1.36057613 |
| 26 | MAP3K7 | 1.30965236 |
| 27 | FGFR2 | 1.26196349 |
| 28 | NEK9 | 1.25575207 |
| 29 | NLK | 1.22878130 |
| 30 | MAP3K12 | 1.21065115 |
| 31 | PRKAA2 | 1.20216663 |
| 32 | KDR | 1.18175506 |
| 33 | JAK2 | 1.15713397 |
| 34 | WNK4 | 1.13982837 |
| 35 | TBK1 | 1.13784011 |
| 36 | ERBB2 | 1.10190952 |
| 37 | KSR2 | 1.06349688 |
| 38 | MET | 1.02425817 |
| 39 | MAP2K3 | 0.98210854 |
| 40 | CDK12 | 0.96799715 |
| 41 | MAPK4 | 0.95964749 |
| 42 | RIPK1 | 0.95868738 |
| 43 | JAK1 | 0.94052423 |
| 44 | PINK1 | 0.93643407 |
| 45 | MAP3K14 | 0.92606383 |
| 46 | EPHB1 | 0.92430858 |
| 47 | PRKCZ | 0.92393050 |
| 48 | MAP3K11 | 0.87895117 |
| 49 | PDK2 | 0.87456956 |
| 50 | MAP3K3 | 0.86381906 |
| 51 | MAP2K6 | 0.85706677 |
| 52 | CDK6 | 0.80494980 |
| 53 | STK38L | 0.76163196 |
| 54 | IRAK3 | 0.75425372 |
| 55 | MAPK15 | 0.75248695 |
| 56 | CSK | 0.75244437 |
| 57 | PRKACG | 0.74784203 |
| 58 | AKT3 | 0.74568300 |
| 59 | EPHA3 | 0.73136246 |
| 60 | PRKG1 | 0.72849773 |
| 61 | DYRK1B | 0.72591522 |
| 62 | MUSK | 0.70511370 |
| 63 | MAPK12 | 0.70279949 |
| 64 | SGK494 | 0.68849718 |
| 65 | PRKAA1 | 0.68291804 |
| 66 | CAMK2G | 0.66803795 |
| 67 | FER | 0.66659401 |
| 68 | PRKACA | 0.65435090 |
| 69 | PTK2 | 0.65325947 |
| 70 | GSK3A | 0.63323712 |
| 71 | CAMK1D | 0.62278982 |
| 72 | SGK3 | 0.61703859 |
| 73 | TIE1 | 0.58730308 |
| 74 | SGK1 | 0.58100192 |
| 75 | PDPK1 | 0.57688566 |
| 76 | PDGFRA | 0.56862563 |
| 77 | IKBKE | 0.55660397 |
| 78 | MYLK | 0.55217607 |
| 79 | FGFR3 | 0.53614652 |
| 80 | MAP2K2 | 0.52662882 |
| 81 | PRKCQ | 0.52506255 |
| 82 | SRC | 0.51563388 |
| 83 | ZAP70 | 0.51457519 |
| 84 | MAPK7 | 0.51396578 |
| 85 | GRK1 | 0.48831449 |
| 86 | TYRO3 | 0.48074369 |
| 87 | PBK | 0.47938442 |
| 88 | ICK | 0.46769567 |
| 89 | CSF1R | 0.46596735 |
| 90 | MAP2K1 | 0.46164498 |
| 91 | RPS6KA3 | 0.44835439 |
| 92 | EPHA4 | 0.44627155 |
| 93 | PRKG2 | 0.44360391 |
| 94 | BRSK2 | 0.43507465 |
| 95 | TAOK2 | 0.42288826 |
| 96 | MAP3K5 | 0.42109207 |
| 97 | MAP3K2 | 0.42078054 |
| 98 | IGF1R | 0.41918971 |
| 99 | RET | 0.41110256 |
| 100 | CSNK1D | 0.40869164 |
| 101 | TGFBR2 | 0.40109876 |
| 102 | NUAK1 | 0.39959746 |
| 103 | CSNK1G1 | 0.39191102 |
| 104 | CDK4 | 0.38143024 |
| 105 | CSNK1E | 0.38058889 |
| 106 | PRKCB | 0.37781850 |
| 107 | SGK2 | 0.36987425 |
| 108 | MAP3K13 | 0.36550963 |
| 109 | PDK1 | 0.36531886 |
| 110 | MAP3K1 | 0.36288515 |
| 111 | CAMKK2 | 0.35830057 |
| 112 | MELK | 0.35761210 |
| 113 | FGFR1 | 0.35553782 |
| 114 | CHUK | 0.34575387 |
| 115 | STK16 | 0.34520295 |
| 116 | MAPKAPK3 | 0.34194364 |
| 117 | MAPK3 | 0.33937368 |
| 118 | EPHA2 | 0.33921641 |
| 119 | PIK3CA | 0.33754029 |
| 120 | MTOR | 0.31578162 |
| 121 | BMX | 0.31275903 |
| 122 | EGFR | 0.30322455 |
| 123 | MAP3K6 | 0.29963752 |
| 124 | PRKCA | 0.29180872 |
| 125 | PRKACB | 0.29039317 |
| 126 | MAP3K9 | 0.27913423 |
| 127 | PRKCG | 0.27297410 |
| 128 | CAMK4 | 0.27266033 |
| 129 | EPHB2 | 0.25740648 |
| 130 | PDK3 | 0.23897350 |
| 131 | PDK4 | 0.23897350 |
| 132 | PAK3 | 0.21921333 |
| 133 | PKN1 | 0.21918725 |
| 134 | SGK223 | 0.20847759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.38167247 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.48875980 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.41238911 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.25028560 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.03720105 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71466038 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.66271849 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.60339639 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.54661711 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49598058 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.42929587 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.32784858 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28857661 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.16735601 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11445389 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.03885223 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.00041994 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.98240447 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94712905 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.93989209 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92369224 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91697923 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.86153255 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.80710255 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.78312171 |
| 26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.72968415 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.72345221 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71621927 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.66685977 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.64003902 |
| 31 | * Bile secretion_Homo sapiens_hsa04976 | 1.54335980 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.54065918 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.53891509 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50960110 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50786678 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47067885 |
| 37 | * Fat digestion and absorption_Homo sapiens_hsa04975 | 1.45869608 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.41462719 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39925826 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38049363 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37248838 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.36711836 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28261585 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.23967162 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17171909 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16877389 |
| 47 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.13682855 |
| 48 | * ABC transporters_Homo sapiens_hsa02010 | 1.11976532 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11753905 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.10526265 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.03866999 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00232202 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00079165 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96668949 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95702394 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92520500 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87254637 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.83992432 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.82236741 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76640012 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76260651 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73374318 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70072425 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66954108 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57738826 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53797253 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50514899 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46551888 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46056629 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34909482 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29910651 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.28191650 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.27349676 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26273295 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.23365249 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20680206 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20514465 |
| 78 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.16263559 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13673887 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.11132242 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07640288 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01361849 |
| 83 | Mineral absorption_Homo sapiens_hsa04978 | 0.00923999 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.00833080 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | -0.2354224 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2303304 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2261022 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2175993 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2017363 |
| 90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2014211 |
| 91 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1973419 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1898279 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1842466 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | -0.1579668 |
| 95 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1485770 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1472861 |
| 97 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1360068 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1291260 |
| 99 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1194431 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1187105 |
| 101 | Amoebiasis_Homo sapiens_hsa05146 | -0.1123898 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1113149 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0811044 |
| 104 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0733925 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0551360 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0078217 |
| 107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0030646 |

